electroCore,

electroCore, Days Sales Outstanding

The Days Sales Outstanding (DSO) of electroCore, (ECOR) as of Oct 17, 2026 is 19.81. In the previous year, Days Sales Outstanding (DSO) was 16.33 — a change of 21.36% (higher).

Days Sales Outstanding

19.81

YoY

21.36%

Last updated:

Days Sales Outstanding (DSO) of electroCore, is 2024 19.81 . Days Sales Outstanding (DSO) of electroCore, was 2023 16.33 . It decreases by 21.36% higher compared to the previous year.

The electroCore, Days Sales Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Sales Outstanding
Date
Days Sales Outstanding
Jan 1, 2017
44.98 USD
Jan 1, 2018
99.25 USD
Jan 1, 2019
76.35 USD
Jan 1, 2020
28.19 USD
Jan 1, 2021
29.46 USD
Jan 1, 2022
16.99 USD
Jan 1, 2023
16.33 USD
Jan 1, 2024
19.81 USD
The electroCore, Days Sales Outstanding history
YEARDays Sales OutstandingYoY
19.81+21.36%
16.33-3.92%
16.99-42.32%
29.46+4.51%
28.19-63.08%
76.35-23.07%
99.25+120.65%
44.98+56.59%
28.72—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

Days Sales Outstanding (DSO) of electroCore, is 19.81 in 2024.

Days Sales Outstanding (DSO) of electroCore, changed from 16.33 to 19.81, representing a 21.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Sales Outstanding (DSO) electroCore, since 2006 – with annual values, charts, and detailed analysis.

DSO measures the average number of days it takes to collect payment after a sale. Lower DSO indicates faster cash collection.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Sales Outstanding (DSO)'s electroCore, with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Sales Outstanding (DSO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Sales Outstanding (DSO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — electroCore,

All Key Metrics — electroCore,